Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
CRMP1 Blocking Peptide (AC1237)
Cat.#: ACPP-1237
Specifications
Despition CRMP1 Blocking Peptide for Immunocompetition, Immunodepletion SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1698 Rat GDNF Protein (AC1698) 2 µg inquiry ACPP-1296 Human FGF 19 Protein (AC1296) 5 µg inquiry ACPP-1564 Human EIF3K Protein (AC1564) 2 µg inquiry ACPP-1419 Human TAC3 Protein (AC1419) 5 µg inquiry ACPP-1221 Bestrophin Blocking Peptide (AC1221) 250 µg inquiry ACPP-1718 Human ASRGL1 Protein (AC1718) 2 µg inquiry ACPP-1429 Human FGF14 Protein (AC1429) 2 µg inquiry ACPP-1254 Luteinizing Hormone Blocking Peptide (AC1254) 250 µg inquiry ACPP-1115 Recombinant Human CD45 Protein (6×His Tag) (AC1115) 50 µg inquiry ACPP-1262 CXCR4 Blocking Peptide (AC1262) 250 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket